Yves Pesant

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer et al. · New England Journal of Medicine · 2017 · 798 citations · Full text

Medicine, Cardiology, Surgery +14

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Philippe Bégin, Jeannie Callum, Erin Jamula et al. · Nature Medicine · 2021 · 275 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 200 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

Richard Vickers, Glenn Tillotson, Richard Nathan et al. · The Lancet Infectious Diseases · 2017 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11